Magistra handles the consultation. You handle the dispensing.

Effective 13 January 2026, the GPhC inspection framework requires UK pharmacies supplying weight-loss medicines (Wegovy, Mounjaro, other GLP-1 jabs) to conduct a two-way consultation rather than relying on a patient questionnaire alone. The consultation can be a video appointment with a qualified clinician, an in-person appointment, or via direct access to the patient's GP record / Summary Care Record (with consent). The pharmacy must also independently verify the patient's height, weight, and BMI rather than accepting self-report. Pharmacies will fail their GPhC inspection if these requirements are not met.

We provide the consultation layer end-to-end: video consultation with a verified specialist physician (booked, conducted, recorded), independent BMI verification (live measurement during the video or partner-clinic measurement), structured consultation records (eating-disorder screening, mental-health red flags, contraindications), dose-escalation protocol with clinician sign-off at each step, and ongoing follow-up. We send the prescription back to your pharmacy for dispensing. You retain the patient relationship for dispensing, refills, and pharmacy services.

Three tiers. Founding (first 25 partners signed by 2026-06-30): £0 platform fee + £10 per Rx referral, includes the partnership agreement, joint-controller GDPR documentation, and a logo-only listing on Magistra's pharmacy directory. Standard: £99/month + £8 per Rx referral, listed on the directory. Premium: £299/month + £5 per Rx referral, includes a co-branded landing page, embedded video-booking widget on your own site, and prioritised patient routing in your geography. Founding is the right tier for most independents; Premium is for clinics with their own marketing reach. Final commercial terms sit on a one-page partnership agreement with a 30-day termination clause.

Patient finds Magistra (organic search, our /economics hub, doctor referral, or your pharmacy's referral). Patient completes our matching form and is matched with a verified specialist. Specialist conducts the GPhC-compliant consultation (video, BMI verification, history, contraindications). If appropriate, prescription is issued and routed to the patient's chosen pharmacy — your pharmacy if you are a partner. You dispense and provide pharmacy services. Magistra retains responsibility for clinical follow-up; you retain pharmacy responsibility.

None beyond your existing PMR / dispensing system. The consultation, BMI verification, and clinical records all happen on Magistra. We can deliver prescriptions to you via the Electronic Prescription Service where supported, or via a secure NHS-compliant transmission method (NHS.net, encrypted email, fax for legacy). If you eventually want a more integrated experience — a co-branded landing page, embedded video booking widget, real-time prescription handoff API — that is available as a paid add-on, but it is not required to participate.

Magistra is the data controller for the consultation, clinical records, and ongoing patient communications. Your pharmacy is the data controller for the dispensing record. We sign a joint-controller agreement (Article 26 GDPR) covering the prescription transmission. The patient signs explicit consent for prescription transmission to their chosen pharmacy. All data flows are documented in the agreement we provide. We hold an ICO registration and the Magistra clinical platform is built to NHS DCB0129 / DCB0160 expectations.

Our compliance is our responsibility. If GPhC tightens further (increased BMI verification frequency, in-person verification thresholds, mental-health-screening protocols), we update our consultation flow at our cost. You receive a written summary of any change that affects your dispensing workflow. The whole point of the partnership is that the regulatory burden sits with the platform, not the dispensing pharmacy.